TRANYLCYPROMINE SULFATE | ADVANZ PHARMA | ||
EQ 10MG BASE | |||
No | No | ||
Expired | Expired | ||
None | None | ||
None | No | ||
PARNATE is a monoamine oxidase inhibitor (MAOI) indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants. PARNATE is not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions. |
3 | 0 | 3 |
Total Other Developers | 2 |
---|
Drugs with Suitability | No |
---|
EQ 10MG BASE | ** | ** | - | - | 3 |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 3 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|---|---|---|---|---|
****** | ******* ****** | ******* ******, *** | *********** | * *** ***** **, ******** *****, *** **** (**) *****-****, ****** ****** (***) | *** |
****** | ******** ****** | ******** ****** *** | *********** | ** **** *****, **** *******, *** ****** (**) *****, ****** ****** (***) | *** |
****** | *********** ** | ********* ** | *********** | ****** ******, *****, ** ****, *********** (***) | *** |
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com